High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.
复制标题
有神经系统症状的COVID-19患者脑脊液自身抗体的高频率。
DOI:
10.1016/j.bbi.2020.12.022
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Prüß H
中科院分区:
文献类型:
--
作者:
Franke C;Ferse C;Kreye J;Reincke SM;Sanchez-Sendin E;Rocco A;Steinbrenner M;Angermair S;Treskatsch S;Zickler D;Eckardt KU;Dersch R;Hosp J;Audebert HJ;Endres M;Ploner JC;Prüß H
COVID-19 intensive care patients can present with neurological syndromes, usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of some virus-neutralizing antibodies cross-reacting with brain tissue suggests the possible involvement of specific autoimmunity. Blood and CSF samples from eleven critically ill COVID-19 patients presenting with unexplained neurological symptoms including myoclonus, oculomotor disturbance, delirium, dystonia and epileptic seizures, were analyzed for anti-neuronal and anti-glial autoantibodies. Using cell-based assays and indirect immunofluorescence on unfixed murine brain sections, all patients showed anti-neuronal autoantibodies in serum or CSF. Antigens included intracellular and neuronal surface proteins, such as Yo or NMDA receptor, but also various specific undetermined epitopes, reminiscent of the brain tissue binding observed with certain human monoclonal SARS-CoV-2 antibodies. These included vessel endothelium, astrocytic proteins and neuropil of basal ganglia, hippocampus or olfactory bulb. The high frequency of autoantibodies targeting the brain in the absence of other explanations suggests a causal relationship to clinical symptoms, in particular to hyperexcitability (myoclonus, seizures). Several underlying autoantigens and their potential molecular mimicry with SARS-CoV-2 still await identification. However, autoantibodies may already now explain some aspects of multi-organ disease in COVID-19 and can guide immunotherapy in selected cases.
登录
查看更多内容
DOI:
10.1016/s1474-4422(20)30308-2
发表时间:
2020-11
期刊:
The Lancet. Neurology
影响因子:
--
作者:
Matschke J;Lütgehetmann M;Hagel C;Sperhake JP;Schröder AS;Edler C;Mushumba H;Fitzek A;Allweiss L;Dandri M;Dottermusch M;Heinemann A;Pfefferle S;Schwabenland M;Sumner Magruder D;Bonn S;Prinz M;Gerloff C;Püschel K;Krasemann S;Aepfelbacher M;Glatzel M
通讯作者:
Glatzel M
DOI:
10.1016/s1474-4422(18)30244-8
发表时间:
2018-09
期刊:
The Lancet. Neurology
影响因子:
--
作者:
Armangue T;Spatola M;Vlagea A;Mattozzi S;Cárceles-Cordon M;Martinez-Heras E;Llufriu S;Muchart J;Erro ME;Abraira L;Moris G;Monros-Giménez L;Corral-Corral Í;Montejo C;Toledo M;Bataller L;Secondi G;Ariño H;Martínez-Hernández E;Juan M;Marcos MA;Alsina L;Saiz A;Rosenfeld MR;Graus F;Dalmau J;Spanish Herpes Simplex Encephalitis Study Group
通讯作者:
Spanish Herpes Simplex Encephalitis Study Group
影响因子:
5.3
作者:
Liotta EM;Batra A;Clark JR;Shlobin NA;Hoffman SC;Orban ZS;Koralnik IJ
通讯作者:
Koralnik IJ
影响因子:
29
作者:
Fang, Boyan;McKeon, Andrew;Lennon, Vanda A.
通讯作者:
Lennon, Vanda A.
影响因子:
64.5
作者:
Kreye J;Reincke SM;Kornau HC;Sánchez-Sendin E;Corman VM;Liu H;Yuan M;Wu NC;Zhu X;Lee CD;Trimpert J;Höltje M;Dietert K;Stöffler L;von Wardenburg N;van Hoof S;Homeyer MA;Hoffmann J;Abdelgawad A;Gruber AD;Bertzbach LD;Vladimirova D;Li LY;Barthel PC;Skriner K;Hocke AC;Hippenstiel S;Witzenrath M;Suttorp N;Kurth F;Franke C;Endres M;Schmitz D;Jeworowski LM;Richter A;Schmidt ML;Schwarz T;Müller MA;Drosten C;Wendisch D;Sander LE;Osterrieder N;Wilson IA;Prüss H
通讯作者:
Prüss H